Any medium-sized pharma-biotech company has two crucial departments in their strategy: the medical department specialized in regulatory affairs and the intellectual property department, which assure the right protection of the results from research.
An adequate clinical development plan and an appropiate patentability strategy must be formulated at the early years of a biotech company, so it is important to have a multidisciplinary team from the company establishment, and even earlier, when the project is still managed by the University’s TTO.
Occasional consultations to specialized medical affairs companies or patent agencies are decisive to decision making. Nevertheless, the conduction of an appropriate monitoring by someone who knows the overall strategy of the company is even more important.
We want to be part of your team, and help you to create a strategic plan from the beginning.